Manufacture, Characterization, and Pharmacodynamic Evaluation of Engineered Ipratropium Bromide Particles

REFERENCES

• Stuart B.O. Deposition and clearance of inhaled particles. Environmental Health Perspectives 1984; 55: 380–384, [CSA]
   Web of Science ®Google Scholar
• Schlesinger R.B. R.O. McClellan, R.F. HendersonDeposition and clearance of inhaled particles. Concepts in Inhalation Toxicology, . Taylor and Francis, Washington, DC 1995
   Google Scholar
• Marlas C., Nadel J.A., Roberts J.M. The muscarinic receptors of airway smooth muscle: their characterization in vitro. J. Appl. Physiol 1982; 52: 1084–1091, [CSA]
   PubMed Web of Science ®Google Scholar
• Cheng J.B., Townley R.G. Comparison of muscarinic and beta-adrenergic receptors between bovine peripheral lung and tracheal smooth muscles. A striking difference. Life Sci 1982; 30: 2079–2086, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Barnes P.J., Nadel J.A., Roberts J.M., Basbaum C.B. Muscarinic receptors in lung and trachea: autoradiographic localization using 3quinuclidinyl benzilate. Eur. J. Pharmacol 1983; 86: 103–106, [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Gupta P.K., Hickey A.J. Contemporary approaches in aerosolized drug delivery to the lung. J. Control. Rel 1991; 17: 129–148, [CSA]
   Web of Science ®Google Scholar
• Govender T., Dangor C.M., Chetty D.J. Microencapsulated Eudragit RS30D-coated controlled-release pellets: the influence of dissolution variables and topographical evaluation. J. Microencapsul 1997; 14(1)1–13, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jist H., Langer R. Responsive polymeric delivery systems. Adv. Drug Dev 2001; 46: 125–148, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hinds W.C. Respiratory deposition. Aerosol Technology. John Wiley & Sons, New York 1999; 211–212
   Google Scholar
• Kanapilly G.M., Raabe O.G., Goh C.H.T., Chimenti R.A. Measurement of in vitro dissolution of aerosol particles for comparison to in vivo dissolution in the lower respiratory tract after inhalation. Health Phys 1972; 24: 459–507, [CSA]
   Web of Science ®Google Scholar
• Sood A., Panchagnula R. Role of dissolution studies in controlled release drug delivery systems. S.T.P. Pharma Sci 1999; 9(2)157–168, [CSA]
   Google Scholar
• Physician's Desk Reference Fifty-eighth. Medical Economics Co., Montvale, NJ 2004
   Google Scholar
• Ratner B., Jackson H.C., Gruehl H.L. Respiratory anaphylaxis. Sensitization, shock, bronchial asthma and death induced in the guinea-pig by the nasal inhalation of dry horse dander. Am. J. Dis. Child 1927; 34: 23–47, [CSA]
   Google Scholar
• Daly I.B., Hebb C. Pulmonary and Bronchial Vascular Systems. Williams and Wilkins, Baltimore, MD 1966
   Google Scholar
• 15. Nials, A.T. The inhibitory potency and duration of action of anti-muscarinic compounds (GR55998Am GR65283A, GR70344A and GR79867A) in the guinea pig superfused, electrically-stimulated trachea. GlaxoWellcome Internal Report, 1990.
   Google Scholar
• Wieslander E., Andersson P., Linden M., Axelsson B., Kallstrom L., Brattsand R., Paulsson I. Importance of particulate antigen for the induction of dual bronchial reaction in guinea-pigs. Agents Actions 1985; 16(1–2)37–38, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Morley J., Chapman I.D., Hoshiko K., Mazzoni L. Acute airway hyperreactivity in the guinea pig. Eur. Resp. Rev 1995; 5(29)202–210, [CSA]
   Google Scholar
• Chong B.T.Y., Agrawal D.K., Romero F.A., Townley R.G. Measurement of bronchoconstriction using whole-body plethysmograph: Comparison of freely moving versus restrained guinea pigs. J. Pharmacol. Toxicol. Methods 1998; 39: 163–168, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Karol M.H. Animal models of occupational asthma. Eur. Resp. J 1994; 7: 555–568, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Allott C.P., Evans D.P., Marshall P.W. A model of irritant-induced bronchoconstriction in the spontaneously breathing guinea-pig. Br. J. Pharmacol 1980; 71: 165–180, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Schwarze J., Hamelmann E., Bradley K.L., Takeda K., Gelfand E.W. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J. Clin. Invest 1997; 100(1)226–233, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Coyle A.J., Lloyd C., Tian J., Nguyen T., Erikkson C., Wang L., Ottoson P., Persson P., Delaney T., Lehar S., Lin S., Poisson L., Meisel C., Kamradt T., Bjerke T., Levinson D., Gutierrez-Ramos J.C. Crucial role of the interleukin 1 receptor family member T1/ST2 in T Helper cell Type 2-mediated lung mucosal immune responses. J. Exp. Med 1999; 190(7)895–902, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schwarze J., Cieslewicz G., Joetham A., Sun L.K., Sun W.N., Chang T.W., Hamelmann E., Gelfand E.W. Antigen-specific immunoglobulin-A prevents increased airway responsiveness and lung eosinophilia after airway challenge in sensitized mice. Am. J. Resp. Crit. Care Med 1998; 158: 519–525, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Myers R.H., Montgomery D.C. Response Surface Methodology. John Wiley & Sons, Inc, New York 1995; 55–61
   Google Scholar
• Edwards D.A., Hanes J., Caponetti G., Hrkach J., Ben-Jebria A., Eskew M.L., Mintzes J., Deaver D., Lotan N., Langer R. Large porous particles for pulmonary drug delivery. Science 1997; 276: 1868–1871, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspensions. J. Pharm. Sci 1961; 50: 874, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• 27. Zanen, P. Aerosol Formulation and Clinical Efficacy of Bronchodilators. Ph.D. Thesis, University of Utrecht, Netherlands, 1998.
   Google Scholar
• Jalil R., Nixon J.R. Biodegradable poly(lactic acid) and poly (lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J. Microencapsul 1990; 7(3)297–325, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• DeLuca P.P., Hickey A.J., Hazrati, Wedlund P., Rypacek F., Kanke M. Porous biodegradable microspheres for parenteral administration. Topics Phar. Sci 1987; 429–442, [CSA]
   Google Scholar
• Krowczynski L. Theoretical principles applied in various extended-release dosage formulations. Extended–Release Dosage Forms. CRC Press, Boca Raton, FL 1987; 31–49
   Google Scholar
• Bodmeier R., Chen H. Evaluation of biodegradable poly(lactide) pellets prepared by direct compression. J. Pharm. Sci 1989; 78(10)819–822, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Huang X., Brazel C.S. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Control. Release 2001; 73: 121–136, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sacchetti M., Van Oort M. A.J. HickeySpray-drying and supercritical fluid particle generation techniques. Inhalation Aerosols, . Marcel Dekker, Inc, New York 1996
   Google Scholar